Document Classification

Section Type: RESULTS

Text: In the treated group, the negative conversion rate of HBV DNA was 42. 6 % (20 / 47), insignificantly different to that in the control group (61. 0 %, 25/41, P > 0. 05) ; the negative conversion rate of HBeAg and HBeAg/anti-HBe sero-conversion rate was 42. 6 % and 36. 2 %, respectively, significantly higher than those in the control group (22. 0 % and 17. 0 %, P < 0. 05) ; the ALT normalizing rate was 74. 4 %, higher than that in the control group (51. 4 %, P < 0. 05) ; the improvement of liver function (ALB and GLB) and clinical symptoms, especially the dizziness, soreness of waist, hypochondrial distending pain, and yellowish urine, were significantly superior to those in the control group (P < 0. 01 or P < 0. 05) ; and the partial response rate was 29. 8 %, insignificant different to that in the control group (14. 6 %, P > 0. 05).